Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 2.15M
2: EX-10.1 Material Contract HTML 116K
3: EX-12 Statement re: Computation of Ratios HTML 59K
4: EX-15 Letter re: Unaudited Interim Financial Info HTML 47K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 43K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 43K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 38K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 38K
15: R1 Document and Entity Information HTML 64K
16: R2 Consolidated Income Statements (Unaudited) HTML 149K
17: R3 Consolidated Comprehensive Income Statements HTML 67K
(Unaudited)
18: R4 Consolidated Balance Sheets HTML 137K
19: R5 Consolidated Balance Sheets (Parenthetical) HTML 68K
20: R6 Consolidated Statements of Changes in Total Equity HTML 74K
(Unaudited)
21: R7 Consolidated Cash Flow Statements (Unaudited) HTML 163K
22: R8 Introduction and Basis of Presentation HTML 52K
23: R9 Significant Accounting Policies HTML 66K
24: R10 Fair Value Disclosures HTML 1.00M
25: R11 Derivative Instruments and Hedging Activities HTML 550K
26: R12 Investment Securities HTML 465K
27: R13 Collateralized Transactions HTML 253K
28: R14 Loans and Allowance for Credit Losses HTML 298K
29: R15 Equity Method Investments HTML 53K
30: R16 Deposits HTML 59K
31: R17 Borrowings and Other Secured Financings HTML 68K
32: R18 Commitments, Guarantees and Contingencies HTML 218K
33: R19 Variable Interest Entities and Securitization HTML 349K
Activities
34: R20 Regulatory Requirements HTML 176K
35: R21 Total Equity HTML 218K
36: R22 Earnings per Common Share HTML 82K
37: R23 Interest Income and Interest Expense HTML 68K
38: R24 Employee Benefit Plans HTML 53K
39: R25 Income Taxes HTML 45K
40: R26 Segment and Geographic Information HTML 180K
41: R27 Customer Contract Revenue Recognition HTML 108K
42: R28 Subsequent Events HTML 42K
43: R29 Significant Accounting Policies (Policy) HTML 62K
44: R30 Fair Value Disclosures (Tables) HTML 1.02M
45: R31 Derivative Instruments and Hedging Activities HTML 554K
(Tables)
46: R32 Investment Securities (Tables) HTML 465K
47: R33 Collateralized Transactions (Tables) HTML 256K
48: R34 Loans and Allowance for Credit Losses (Tables) HTML 306K
49: R35 Equity Method Investments (Tables) HTML 51K
50: R36 Deposits (Tables) HTML 59K
51: R37 Borrowings and Other Secured Financings (Tables) HTML 67K
52: R38 Commitments, Guarantees and Contingencies (Tables) HTML 181K
53: R39 Variable Interest Entities and Securitization HTML 348K
Activities (Tables)
54: R40 Regulatory Requirements (Tables) HTML 165K
55: R41 Total Equity (Tables) HTML 221K
56: R42 Earnings per Common Share (Tables) HTML 81K
57: R43 Interest Income and Interest Expense (Tables) HTML 66K
58: R44 Employee Benefit Plans (Tables) HTML 52K
59: R45 Segment and Geographic Information (Tables) HTML 185K
60: R46 Customer Contract Revenue Recognition (Tables) HTML 109K
61: R47 Significant Accounting Policies (Details) HTML 46K
62: R48 Fair Value Disclosures (Assets and Liabilities HTML 204K
Measured at Fair Value on a Recurring Basis)
(Details)
63: R49 Fair Value Disclosures (Rollforward of Level 3 HTML 170K
Assets and Liabilities Measured at Fair Value on a
Recurring Basis) (Details)
64: R50 Fair Value Disclosures (Valuation Techniques and HTML 230K
Sensitivity of Unobservable Inputs Used in
Recurring Level 3 Fair Value Measurements)
(Details)
65: R51 Fair Value Disclosures (Measured Based on Net HTML 61K
Asset Value) (Details)
66: R52 Fair Value Disclosures (Earnings Impact of HTML 46K
Instruments under the Fair Value Option) (Details)
67: R53 Fair Value Disclosures (Gains (Losses) Due to HTML 58K
Changes in Instrument-Specific Credit Risk)
(Details)
68: R54 Fair Value Disclosures (Borrowings Measured at HTML 54K
Fair Value) (Details)
69: R55 Fair Value Disclosures (Excess of Contractual HTML 44K
Principal Amount Over Fair Value) (Details)
70: R56 Fair Value Disclosures (Fair Value of Loans in HTML 42K
Nonaccrual Status) (Details)
71: R57 Fair Value Disclosures (Assets Measured at Fair HTML 73K
Value on a Non-Recurring Basis) (Details)
72: R58 Fair Value Disclosures (Financial Instruments Not HTML 126K
Measured at Fair Value) (Details)
73: R59 Derivative Instruments and Hedging Activities HTML 185K
(Derivative Fair Values) (Details)
74: R60 Derivative Instruments and Hedging Activities HTML 108K
(Derivative Notionals) (Details)
75: R61 Derivative Instruments and Hedging Activities HTML 81K
(Gains (Losses) on Accounting Hedges and Trading
Revenues by Product Type) (Details)
76: R62 Derivative Instruments and Hedging Activities HTML 52K
(Credit Risk-Related Contingencies) (Details)
77: R63 Derivative Instruments and Hedging Activities HTML 120K
(Credit Derivatives and Other Credit Contracts)
(Details)
78: R64 Investment Securities (AFS and HTM Securities) HTML 134K
(Details)
79: R65 Investment Securities (Investment Securities in an HTML 147K
Unrealized Loss Position) (Details)
80: R66 Investment Securities (Investment Securities by HTML 202K
Contractual Maturity) (Details)
81: R67 Collateralized Transactions (Offsetting of Certain HTML 115K
Collateralized Transactions) (Details)
82: R68 Collateralized Transactions (Gross Secured HTML 85K
Financing Balances) (Details)
83: R69 Collateralized Transactions (Assets Pledged) HTML 45K
(Details)
84: R70 Collateralized Transactions (Collateral Received) HTML 43K
(Details)
85: R71 Collateralized Transactions (Customer Margin HTML 39K
Lending and Other) (Details)
86: R72 Collateralized Transactions (Restricted Cash and HTML 46K
Segregated Securities) (Details)
87: R73 Loans and Allowance for Credit Losses (Loans Held HTML 126K
for Investment and Held for Sale) (Details)
88: R74 Loans and Allowance for Credit Losses (Impaired HTML 66K
Loans) (Details)
89: R75 Loans and Allowance for Credit Losses (Tdr) HTML 43K
(Details)
90: R76 Loans and Allowance for Credit Losses (Allowance HTML 92K
for Loan Losses and Lending Commitments
Rollforward) (Details)
91: R77 Loans and Allowance for Credit Losses (Employee HTML 49K
Loans) (Details)
92: R78 Equity Method Investments (Equity Method HTML 45K
Investment Balances) (Details)
93: R79 Equity Method Investments (Investees) (Details) HTML 49K
94: R80 Deposits (Details) HTML 63K
95: R81 Borrowings and Other Secured Financings (Long-Term HTML 55K
Borrowings) (Details)
96: R82 Borrowings and Other Secured Financings (Other HTML 46K
Secured Financings) (Details)
97: R83 Commitments, Guarantees and Contingencies HTML 79K
(Commitments) (Details)
98: R84 Commitments, Guarantees and Contingencies HTML 111K
(Obligations under Guarantee Arrangements)
(Details)
99: R85 Commitments, Guarantees and Contingencies HTML 105K
(Contingencies) (Details)
100: R86 Variable Interest Entities and Securitization HTML 50K
Activities (Consolidated VIEs) (Details)
101: R87 Variable Interest Entities and Securitization HTML 76K
Activities (Assets and Liabilities by Balance
Sheet Caption) (Details)
102: R88 Variable Interest Entities and Securitization HTML 102K
Activities (Non-Consolidated VIEs) (Details)
103: R89 Variable Interest Entities and Securitization HTML 85K
Activities (Transfers of Assets with Continuing
Involvement 1) (Details)
104: R90 Variable Interest Entities and Securitization HTML 70K
Activities (Transfers of Assets with Continuing
Involvement 2) (Details)
105: R91 Variable Interest Entities and Securitization HTML 50K
Activities (Proceeds from New Securitization
Transactions and Sales of Loans) (Details)
106: R92 Variable Interest Entities and Securitization HTML 53K
Activities (Assets Sold with Retained Exposure)
(Details)
107: R93 Variable Interest Entities and Securitization HTML 42K
Activities (Failed Sales) (Details)
108: R94 Regulatory Requirements (Narrative) (Details) HTML 45K
109: R95 Regulatory Requirements (Capital Measures) HTML 82K
(Details)
110: R96 Regulatory Requirements (U.S. Bank Subsidiaries' HTML 86K
Regulatory Capital and Capital Ratios) (Details)
111: R97 Regulatory Requirements (Broker-Dealer Regulatory HTML 47K
Capital Requirements) (Details)
112: R98 Total Equity (Dividends and Share Repurchases) HTML 56K
(Details)
113: R99 Total Equity (Preferred Stock General Disclosure) HTML 42K
(Details)
114: R100 Total Equity (Preferred Stock Outstanding) HTML 83K
(Details)
115: R101 Total Equity (Aoci) (Details) HTML 59K
116: R102 Total Equity (Components of Period Changes in OCI HTML 175K
) (Details)
117: R103 Total Equity (Cumulative Adjustments to Retained HTML 51K
Earnings) (Details)
118: R104 Earnings per Common Share (Calculation of Basic HTML 101K
and Diluted EPS) (Details)
119: R105 Interest Income and Interest Expense (Details) HTML 66K
120: R106 Employee Benefit Plans (Net Periodic Benefit HTML 53K
Expense (Income)) (Details)
121: R107 Segment and Geographic Information (Selected HTML 97K
Financial Information by Business Segment)
(Details)
122: R108 Segment and Geographic Information (Assets by HTML 47K
Business Segment) (Details)
123: R109 Segment and Geographic Information (Additional HTML 43K
Information - Investment Management) (Details)
124: R110 Segment and Geographic Information (Net Revenues HTML 46K
by Region) (Details)
125: R111 Customer Contract Revenue Recognition (Customer HTML 81K
Contract Renenues) (Details)
126: R112 Customer Contract Revenue Recognition (Change in HTML 63K
Revenue) (Details)
127: R113 Customer Contract Revenue Recognition (Balance HTML 51K
Sheet Amounts) (Details)
128: R114 Customer Contract Revenue Recognition (Future HTML 49K
Expected Revenues) (Details)
130: XML IDEA XML File -- Filing Summary XML 262K
129: EXCEL IDEA Workbook of Financial Reports XLSX 196K
9: EX-101.INS XBRL Instance -- ms-20180331 XML 13.13M
11: EX-101.CAL XBRL Calculations -- ms-20180331_cal XML 640K
12: EX-101.DEF XBRL Definitions -- ms-20180331_def XML 3.52M
13: EX-101.LAB XBRL Labels -- ms-20180331_lab XML 6.88M
14: EX-101.PRE XBRL Presentations -- ms-20180331_pre XML 4.78M
10: EX-101.SCH XBRL Schema -- ms-20180331 XSD 699K
131: ZIP XBRL Zipped Folder -- 0001193125-18-152899-xbrl Zip 913K
Filing Submission 0001193125-18-152899 – SGML Text
To view the SGML, please refresh this page.
↑Top
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Fri., Apr. 19, 6:01:46.2am ET 
